News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
DEBRA Research and the University Medical Center Groningen Launch Dedicated Clinical Trial Site for Epidermolysis Bullosa
DEBRA Research and University Medical Center Groningen launch dedicated clinical trial site for Epidermolysis Bullosa, strengthening research infrastructure and supporting patient-focused initiatives -
-
-
COMMUNIQUÉ DE PRESSE
DEBRA Research Invests in Eliksa Therapeutics to Advance ELK-003, a Biological Eye Drop for Epidermolysis Bullosa-Related Ocular Complications
DEBRA Research invests in Eliksa Therapeutics to advance ELK-003, a biological eye drop for Epidermolysis Bullosa-related ocular complications, supported by a syndicate of mission-driven organizations -
